Dudediligence.

Dyne Therapeutics, Inc

DYNNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$97.1MSep ’24−$89.5MDec ’24−$115.4MMar ’25−$110.9MJun ’25−$108.0MSep ’25$334.3MDec ’25−$120.9MMar ’26−$178.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$150.0M−$171.0M−$242.2M−$343.9M−$468.2M
Net income−$149.3M−$168.1M−$235.9M−$317.4M−$446.20
Operating cash flow−$119.6M−$153.6M−$188.2M−$292.4M−$403.2M
Free cash flow−$123.2M−$156.7M−$188.9M−$294.7M−$405.1M
Cash$200.8M$172.1M$121.6M$435.4M$893.4M
Debtnone on filenone on filenone on file$0.00$148.9M
Shares outstanding51.6M55.6M61.5M102.3M165.0M